Warfarin Pharmacogenomics in Diverse Populations.

Abstract:

:Genotype-guided warfarin dosing algorithms are a rational approach to optimize warfarin dosing and potentially reduce adverse drug events. Diverse populations, such as African Americans and Latinos, have greater variability in warfarin dose requirements and are at greater risk for experiencing warfarin-related adverse events compared with individuals of European ancestry. Although these data suggest that patients of diverse populations may benefit from improved warfarin dose estimation, the vast majority of literature on genotype-guided warfarin dosing, including data from prospective randomized trials, is in populations of European ancestry. Despite differing frequencies of variants by race/ethnicity, most evidence in diverse populations evaluates variants that are most common in populations of European ancestry. Algorithms that do not include variants important across race/ethnic groups are unlikely to benefit diverse populations. In some race/ethnic groups, development of race-specific or admixture-based algorithms may facilitate improved genotype-guided warfarin dosing algorithms above and beyond that seen in individuals of European ancestry. These observations should be considered in the interpretation of literature evaluating the clinical utility of genotype-guided warfarin dosing. Careful consideration of race/ethnicity and additional evidence focused on improving warfarin dosing algorithms across race/ethnic groups will be necessary for successful clinical implementation of warfarin pharmacogenomics. The evidence for warfarin pharmacogenomics has a broad significance for pharmacogenomic testing, emphasizing the consideration of race/ethnicity in discovery of gene-drug pairs and development of clinical recommendations for pharmacogenetic testing.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Kaye JB,Schultz LE,Steiner HE,Kittles RA,Cavallari LH,Karnes JH

doi

10.1002/phar.1982

subject

Has Abstract

pub_date

2017-09-01 00:00:00

pages

1150-1163

issue

9

eissn

0277-0008

issn

1875-9114

journal_volume

37

pub_type

杂志文章,评审
  • Methods to assess the economic outcomes of clinical pharmacy services.

    abstract::Studies that demonstrate the clinical and economic burden of drug misadventures have been published. The economic burden of drug misadventures likely exceeds $100 billion annually in the United States alone. Clinical pharmacy services (CPS) have been shown to reduce negative clinical outcomes and costs of drug therapy...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.16.243s.35018

    authors: Schumock GT

    更新日期:2000-10-01 00:00:00

  • Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.

    abstract::In patients infected with chronic hepatitis B virus (HBV) that goes untreated, therapeutic options are limited once the disease decompensates, and orthotopic liver transplantation is often the only treatment available to save the patient's life. After liver transplantation, combined therapy with hepatitis B immune glo...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1306

    authors: McGonigal KH,Bajjoka IE,Abouljoud MS

    更新日期:2013-09-01 00:00:00

  • Interpreting meta-analyses of pharmacologic interventions: the pitfalls and how to identify them.

    abstract::Meta-analyses are key components of evidence-based decision making. The numbers of meta-analyses published in different areas of health care increased dramatically during the past 10 years. Many of them covered different pharmacologic interventions, making them useful resources to clinical pharmacists. Although a well...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.9.741.31541

    authors: Etminan M,Levine M

    更新日期:1999-06-01 00:00:00

  • Vitamin K to reverse excessive anticoagulation: a review of the literature.

    abstract::We conducted an extensive literature review to evaluate the appropriate use, route, and dose of vitamin K to reverse excessive anticoagulation. Issues such as sample size, study design, different patient populations, and various study end points confounded results. Of 18 studies published, 8 enrolled 229 patients to e...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.19.18.1415.30896

    authors: Taylor CT,Chester EA,Byrd DC,Stephens MA

    更新日期:1999-12-01 00:00:00

  • National evaluation of prescriber drug dispensing.

    abstract:OBJECTIVE:To describe the legal, professional, and consumer status of prescribers dispensing legend and over-the-counter drugs in the United States. METHODS:Legal and academic databases were searched to identify those states that permit prescribers to dispense medications to patients and any limitations on such practi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1461

    authors: Munger MA,Ruble JH,Nelson SD,Ranker L,Petty RC,Silverstein S,Barton E,Feehan M

    更新日期:2014-10-01 00:00:00

  • Quinupristin-dalfopristin: an overview.

    abstract::Synercid (RP 59500), the first injectable streptogramin antibiotic, is composed of two semisynthetic pristinamycin derivatives, quinupristin and dalfopristin. Individually, each component has bacteriostatic activity against staphylococci and streptococci, but together, the agents exhibit synergy, leading to bactericid...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.19.1469.34858

    authors: Delgado G Jr,Neuhauser MM,Bearden DT,Danziger LH

    更新日期:2000-12-01 00:00:00

  • Fatal clindamycin-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.

    abstract::Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, complex, idiosyncratic drug reaction that can be fatal. Systemic symptoms include lymphadenopathy, hepatic failure, and possibly renal failure. The syndrome has been primarily associated with anticonvulsants, whereas antimicrobials are less ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1142

    authors: Miller Quidley A,Bookstaver PB,Gainey AB,Gainey MD

    更新日期:2012-12-01 00:00:00

  • Unfractionated heparin dosing nomograms: road maps to where?

    abstract::Weight-adjusted nomograms have been a significant advance in the use of unfractionated heparin (UFH). Clinical trials have demonstrated the ability of weight-adjusted nomograms to achieve a therapeutic activated partial thromboplastin time (aPTT) more rapidly than with standard UFH dosing. Despite this advantage, a si...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.12.142s.36113

    authors: Dobesh PP,Heparin Consensus Group.

    更新日期:2004-08-01 00:00:00

  • Pharmacokinetics of daptomycin in a critically ill adolescent with vancomycin-resistant enterococcal endocarditis.

    abstract::Daptomycin is a lipopeptide antibiotic active against multidrug-resistant gram-positive organisms. Our search of the literature found no published pediatric pharmacokinetic data. We report the use of pharmacokinetic analysis of daptomycin in a 13-year-old boy with vancomycin-resistant Enterococcus faecium endocarditis...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.5.694

    authors: Akins RL,Haase MR,Levy EN

    更新日期:2006-05-01 00:00:00

  • Vigabatrin for infantile spasms.

    abstract::Infantile spasms describe a pediatric epilepsy syndrome characterized by frequent clusters of brief symmetric muscle contractions; the condition is often associated with developmental delay. When infantile spasms are accompanied by hypsarrhythmia on electroencephalogram, the condition is labeled West syndrome. The mai...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.3.298

    authors: Pesaturo KA,Spooner LM,Belliveau P

    更新日期:2011-03-01 00:00:00

  • Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.

    abstract::Patients with various rheumatologic and inflammatory disease states commonly require drugs known to decrease the inflammatory or autoimmune response for adequate control of their condition. Such drugs include nonsteroidal antiinflammatory drugs (NSAIDs), cyclooxygenase (COX)-2 inhibitors, corticosteroids, disease-modi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.11.1566

    authors: Busti AJ,Hooper JS,Amaya CJ,Kazi S

    更新日期:2005-11-01 00:00:00

  • Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.

    abstract::The U.S. population continues to experience an alarmingly high rate of unintended pregnancies that have an impact on individual families and society alike. Lack of effective contraception accounts for most unintended pregnancies, along with incorrect use of contraceptives. The most common reversible contraceptive meth...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1457

    authors: Rafie S,McIntosh J,Shealy KM,Borgelt LM,Forinash A,Shrader SP,Koepf ER,McClendon KS,Griffin BL,Horlen C,Karaoui LR,Rowe EL,Lodise NM,Wigle PR

    更新日期:2014-09-01 00:00:00

  • Adjunctive Use of Cidofovir and Intravenous Immunoglobulin to Treat Invasive Adenoviral Disease in Solid Organ Transplant Recipients.

    abstract:BACKGROUND:Infections with adenoviruses (ADVs) can result in considerable mortality and morbidity in solid organ transplant (SOT) recipients. Standard therapy for ADV infections in transplant recipients is not established. At our institution, intravenous cidofovir and immunoglobulin have been used to treat disseminated...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2194

    authors: Permpalung N,Mahoney MV,Alonso CD

    更新日期:2018-12-01 00:00:00

  • Management of coronary heart disease risk factors and progression with calcium channel blockers.

    abstract::The death rate from coronary heart disease (CHD) declined by 25% in the United States during 1987-1997, but the actual number of deaths fell by only 9%. Modifiable risk factors for CHD include hypertension, elevated low-density lipoprotein cholesterol, reduced high-density lipoprotein cholesterol, cigarette smoking, a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.14.195s.34602

    authors: Pieper JA

    更新日期:2001-09-01 00:00:00

  • Antimicrobial stewardship in patients with cancer.

    abstract::Consensus guidelines recommend antimicrobial stewardship in all hospitals with the following goals in mind: appropriate and judicious use of antimicrobial agents leading to increased drug safety, reduced antimicrobial utilization, reduction in the development and selection of resistant organisms, cost containment, and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2012.01162.x

    authors: Tverdek FP,Rolston KV,Chemaly RF

    更新日期:2012-08-01 00:00:00

  • Evaluation of dabigatran bleeding adverse reaction reports in the FDA adverse event reporting system during the first year of approval.

    abstract:STUDY OBJECTIVE:Evaluate dabigatran adverse event reports with a reported bleeding event and/or reported fatal outcome compared with warfarin. DESIGN:Retrospective analysis of the FDA Adverse Event Reporting System (FAERS) database. MEASUREMENTS AND MAIN RESULTS:We identified reports from October 1, 2010, through Dec...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1415

    authors: McConeghy KW,Bress A,Qato DM,Wing C,Nutescu EA

    更新日期:2014-06-01 00:00:00

  • Therapeutic drug monitoring of continuous-infusion acylovir for disseminated herpes simplex virus infection in a neonate receiving concurrent extracorporeal life support and continuous renal replacement therapy.

    abstract::Disseminated herpes simplex virus (HSV) infection in neonates represents a devastating entity that yields high mortality. Acyclovir is the primary antiviral agent used to treat life-threatening HSV infections in neonates; however, even though the agent has reduced morbidity overall from these infections, mortality wit...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1526

    authors: Cies JJ,Moore WS 2nd,Miller K,Small C,Carella D,Conley S,Parker J,Shea P,Chopra A

    更新日期:2015-02-01 00:00:00

  • Association of the histamine N-methyltransferase C314T (Thr105Ile) polymorphism with atopic dermatitis in Caucasian children.

    abstract:STUDY OBJECTIVE:To investigate potential associations between the histamine N-methyltransferase (HNMT) gene, HNMT, C314T (Thr105Ile) polymorphism and atopic dermatitis in a cohort of Caucasian children. DESIGN:Prospective, multicenter, genotype-association study. SETTING:Four academic, tertiary care medical centers w...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1592/phco.28.12.1495

    authors: Kennedy MJ,Loehle JA,Griffin AR,Doll MA,Kearns GL,Sullivan JE,Hein DW

    更新日期:2008-12-01 00:00:00

  • Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy, safety, and costs of rabbit antithymocyte globulin (TMG) induction in patients who received kidney transplants from living unrelated donors. DESIGN:Retrospective cohort study. SETTING:Large academic medical center. PATIENTS:Eighty-seven patients who received kidney transplan...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.29.10.1166

    authors: Miller JT,Collins CD,Stuckey LJ,Luan FL,Englesbe MJ,Magee JC,Park JM

    更新日期:2009-10-01 00:00:00

  • Complementary and alternative medicine use among individuals participating in research: implications for research and practice.

    abstract:STUDY OBJECTIVES:To determine the frequency and type of complementary and alternative medicine (CAM) use among healthy volunteers participating in research, and to investigate the potential for interactions between commonly used CAM modalities and various drugs. DESIGN:Prospective evaluation. SETTING:University gener...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.12.1794

    authors: Welder GJ,Wessel TR,Arant CB,Schofield RS,Zineh I

    更新日期:2006-12-01 00:00:00

  • A double-blind, placebo-controlled evaluation of intranasal metoclopramide in the prevention of postoperative nausea and vomiting.

    abstract::Nausea and vomiting are common complaints in the postoperative period and contribute to patient distress and delay of discharge for outpatient surgical procedures. Laparoscopic procedures are associated with a high incidence of postoperative nausea and vomiting (PONV) episodes. Parenteral use of metoclopramide prevent...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Wagner BK,Berman SL,Devitt PA,Halvorsen MB,O'Hara DA

    更新日期:1996-11-01 00:00:00

  • Management of herpesvirus infections in the healthy host.

    abstract::Human herpesvirus infections continue to be a concern in immunocompetent as well as immunocompromised hosts. They are often life threatening in the immunocompromised patient. In the healthy immunocompetent person the infections tend to be self-limited, although they can directly or indirectly cause periods of severe d...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Dudley MN

    更新日期:1995-09-01 00:00:00

  • Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.

    abstract:STUDY OBJECTIVE:To determine if development of acneiform rash is a predictor of objective response rate with lapatinib. DESIGN:Subanalysis of data from a prospective, phase II study. SETTING:Academic breast care clinic. PATIENTS:Forty-nine treatment-naïve patients with human epidermal growth factor receptor-2 (HER2)...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1308

    authors: Parma J,Pavlick A,Schiff R,Osborne CK,Chang JC,Rimawi M,Trivedi MV

    更新日期:2013-10-01 00:00:00

  • Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.

    abstract::Oral anticoagulation with warfarin requires routine monitoring of prothrombin time, expressed as the international normalized ratio (INR). Patient self-testing for INR is common in Europe but not in the United States. In order to determine the frequency of INR self-testing among patients whose anticoagulant therapy is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.2.265.56949

    authors: Wittkowsky AK,Sekreta CM,Nutescu EA,Ansell J

    更新日期:2005-02-01 00:00:00

  • Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.

    abstract:STUDY OBJECTIVE:To determine the appropriate compartmental and noncompartmental pharmacokinetic parameters for intravenous piperacillin and tazobactam. DESIGN:Sequential selection of patients entered into a randomized, open-label clinical efficacy trial. SETTING:Los Angeles County-University of Southern California Me...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Jhee SS,Kern JW,Burm JP,Yellin AE,Gill MA

    更新日期:1995-07-01 00:00:00

  • Effect of telephone follow-up on the physical well-being dimension of quality of life in patients with cancer.

    abstract:OBJECTIVE:To evaluate the effect of telephone follow-up on the physical well-being dimension of health-related quality of life in patients with cancer. DESIGN:Randomized, controlled trial. SETTING:Public teaching hospital. PATIENTS:One hundred fifty patients with cancer who were discharged to home from the hospital....

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.22.15.1301.33480

    authors: Beney J,Devine EB,Chow V,Ignoffo RJ,Mitsunaga L,Shahkarami M,McMillan A,Bero LA

    更新日期:2002-10-01 00:00:00

  • Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

    abstract:STUDY OBJECTIVE:To determine whether early administration of adjuvant β-lactam in combination with vancomycin (COMBO) affects clinical outcomes compared to standard vancomycin therapy alone (STAN) among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection. DESIGN:Retrospective, multic...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.2034

    authors: Casapao AM,Jacobs DM,Bowers DR,Beyda ND,Dilworth TJ,REACH-ID Study Group.

    更新日期:2017-11-01 00:00:00

  • Patient drug attributions and postmarketing surveillance.

    abstract::Although studies have shown that patients can distinguish probable adverse drug reactions (ADRs) from adverse clinical events (ACEs) caused by other factors, it is not known whether these attribution judgments add any independent validity to other accepted methods of identifying ADRs, such as physician assessments or ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Fisher S,Bryant SG,Kent TA,Davis JE

    更新日期:1994-03-01 00:00:00

  • Treatment options for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.

    abstract::Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a rare neurodegenerative disease caused by the decreased ability of cells to produce sufficient energy in the form of adenosine 5'-triphosphate. Although it is one of the most common maternally inherited mitochondrial...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.30.11.1179

    authors: Santa KM

    更新日期:2010-11-01 00:00:00

  • Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination.

    abstract::Cytochrome P450 3A5 (CYP3A5) and cytochrome P450 3A4 (CYP3A4) are the predominate enzymes responsible for tacrolimus metabolism. The presence of CYP3A4 and CYP3A5 genetic variants significantly affects tacrolimus clearance and dose requirements. CYP3A5*3 is a loss-of-function variant resulting in no CYP3A5 enzyme prod...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.2131

    authors: Scheibner A,Remmel R,Schladt D,Oetting WS,Guan W,Wu B,Dorr C,Israni A,Jacobson PA

    更新日期:2018-07-01 00:00:00